(R)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol-13CD3 hydrochloride; (6aR)-5,6,6a,7-Tetrahydro-6-(methyl-d3)-4H-dibenzo[de,g]quinoline-10,11-diol Hydrochloride; 6a?-Aporphine-10,11-diol-d3 Hydrochloride; (-)-10,11-Dihydroxy-aporphine-13CD3 Hydrochloride; (-)-Apomorphine-13CD3 Chloride; (R)-(-)-Apomorphine-13CD3 Chloride; Apokyn-13CD3; Apomorphin-13CD3; Apomorphine-13CD3; Ixense-13CD3; l-Apomorphine-13CD3
Apomorphine-13C-d3 HCl is a fully characterized chemical compound used as a reference standard of API Lumacaftor. The standard offered is compliant with regulatory guidelines. Apomorphine-13C-d3 HCl is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - NA
